Lindsley F. Kimball Research Institute

Our Research

LFKRI is the research branch of New York Blood Center. Since its establishment in 1964, LFKRI's research efforts have paved the way for new blood-related products, techniques and therapies and has resulted in numerous landmark patents and licenses.

About LFKRI

Areas of Research

LFKRI continues to be at the forefront of blood disease research

People_IconCreated with Sketch.

Meet Our Investigators

LFKRI’s pioneering investigators have a remarkable depth of experience and expertise in their fields

Microscope_IconCreated with Sketch.

Areas of Research

Learn more about our areas of research

Beaker_IconCreated with Sketch.

Donate to Research

It takes more than blood to save a life

Research News

NYBC Sickle Cell Study Highlighted as Plenary Paper in "Blood" Journal

Scientists at LFKRI have identified a subset of white blood cells which can remove the sickle blood cells attached to the cells of the vessel wall.

HIV-1 Inhibitor Shows Promise in Pre-Clinical Experimental Model

Dr. Asim Debnath’s laboratory at the New York Blood Center has been devoted to discovering novel drugs against HIV.

LFKRI Scientists Identify Novel Cells to Help Platelet Biomanufacturing

Previously it was unknown how formed platelets in the circulation maintain a low basal activati...

ExCellThera Enters into Agreement with CCS, a division of NYBC

This manufacturing and collaboration agreement covers the clinical grade production of ExCellThera’s lead cell therapy product, ECT-001.

Viral Immunology Lab Identifies Zika Subunit Vaccine

Zika virus remains a threat to public health due to its close association with microcephaly and other severe birth defects​.

Dr. Lanying Du Receives Her First NIH R01 Grant on MERS Vaccines

MERS-CoV, a newly emerging, highly pathogenic infectious virus, continues to threat public health worldwide with high mortality rate (about 35%).

Products & Services

We offer a comprehensive menu of services and products to support and manage the full spectrum of transfusion medicine, regenerative medicine and cellular-therapy related research projects, from basic science to full scale clinical trials.

About NYBCe

New York Blood Center Enterprises (NYBCe) is one of the largest independent, community-based, nonprofit blood centers in the United States.